Get startedLog in
    Picture of Zynerba Pharmaceuticals logo

    ZYNE — Zynerba Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall Cap
    All News

    Brief: Zynerba Pharmaceuticals Announces Update On RECONNECT, Pivotal Phase 3 Trial Of Zygel

    Picture of Zynerba Pharmaceuticals logoZynerba Pharmaceuticals
    21/12/2022 12:03
    Dec 21 (Reuters) - Zynerba Pharmaceuticals Inc  ZYNE.O :
    * ZYNERBA PHARMACEUTICALS ANNOUNCES UPDATE ON RECONNECT, THE
PIVOTAL PHASE 3 TRIAL OF ZYGEL™ IN FRAGILE X SYNDROME
    * ZYNERBA PHARMACEUTICALS INC- CASH RUNWAY EXTENDED TO
MID-YEAR
2024
    * ZYNERBA PHARMACEUTICALS INC - TOPLINE RESULTS NOW EXPECTED
FIRST
HALF OF 2024

Source text for Eikon:  ID:nGNX1wvh8P 
Further company coverage:  ZYNE.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Zynerba Pharmaceuticals

    See all news